L’hyperplasie pseudo-angiomateuse du stroma mammaire

Vuitch, 1986, Pseudoangiomatous hyperplasia of mammary stroma, Hum Pathol, 17, 185, 10.1016/S0046-8177(86)80292-1 Ibrahim, 1989, Pseudoangiomatous hyperplasia of mammary stroma, Cancer, 63, 1154, 10.1002/1097-0142(19890315)63:6<1154::AID-CNCR2820630619>3.0.CO;2-Q Tavassoli, 1999 Powell, 1995, Pseudoangiomatous Stromal Hyperplasia (PASH). A mammary stromal tumor with myofibroblasic differentiation, Am J Surg Pathol, 19, 270, 10.1097/00000478-199503000-00004 Cohen, 1996, Pseudoangiomatous stromal hyperplasia : mammographic, sonographic, and clinical patterns, Radiology, 198, 117, 10.1148/radiology.198.1.8539361 Piccoli, 1999, Developing assymetric breast tissue, Radiology, 211, 111, 10.1148/radiology.211.1.r99ap42111 Moore, 2001, Expression of CD34 and Bcl2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast, Histopathology, 38, 62, 10.1046/j.1365-2559.2001.01053.x Fisher, 1992, Mammary hamartoma - a review of 35 cases, Histopathology, 20, 99, 10.1111/j.1365-2559.1992.tb00938.x Longacre, 1986, A correlative morphologic study of human breast and endometrium in the menstrual cycle, Am J Surg Pathol, 10, 382, 10.1097/00000478-198606000-00003 Anderson, 1991, Immunocytochemical analysis of estrogen and progesterone receptors in benign stromal lesions of the breast. Evidence for hormonal etiology in pseudoangiomatous hyperplasia of mammary stroma, Am J Surg Pathol, 15, 145, 10.1097/00000478-199102000-00007 Pruthi, 2001, Tamoxifen in the management of pseudoangiomatous stromal hyperplasia, Breast J, 7, 434, 10.1046/j.1524-4741.2001.07611.x